{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"22.11","value":"60.3"},{"groupId":"OG001","spread":"21.13","value":"61.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"211"},{"groupId":"OG001","value":"210"}],"units":"Participants"}],"title":"Global Health Status/QoL Score: Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"25.93","value":"-3.0"},{"groupId":"OG001","spread":"26.89","value":"-8.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"146"},{"groupId":"OG001","value":"124"}],"units":"Participants"}],"title":"Global Health Status/QoL Score: Change from Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"22.63","value":"69.4"},{"groupId":"OG001","spread":"20.38","value":"75.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"211"},{"groupId":"OG001","value":"210"}],"units":"Participants"}],"title":"Physical Functioning Score: Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"22.82","value":"-7.5"},{"groupId":"OG001","spread":"27.51","value":"-13.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"146"},{"groupId":"OG001","value":"125"}],"units":"Participants"}],"title":"Physical Functioning Score: Change from Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"30.88","value":"66.9"},{"groupId":"OG001","spread":"28.55","value":"73.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"211"},{"groupId":"OG001","value":"210"}],"units":"Participants"}],"title":"Role Functioning Score: Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"35.41","value":"-11.8"},{"groupId":"OG001","spread":"36.72","value":"-18.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"146"},{"groupId":"OG001","value":"126"}],"units":"Participants"}],"title":"Role Functioning Score: Change from Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"20.96","value":"76.0"},{"groupId":"OG001","spread":"22.10","value":"77.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"211"},{"groupId":"OG001","value":"210"}],"units":"Participants"}],"title":"Emotional Functioning Score: Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"23.80","value":"-2.5"},{"groupId":"OG001","spread":"22.41","value":"-5.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"146"},{"groupId":"OG001","value":"124"}],"units":"Participants"}],"title":"Emotional Functioning Score: Change from Baselline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"18.29","value":"84.6"},{"groupId":"OG001","spread":"17.60","value":"86.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"211"},{"groupId":"OG001","value":"210"}],"units":"Participants"}],"title":"Cognitive Functioning Score: Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"22.65","value":"-7.2"},{"groupId":"OG001","spread":"24.38","value":"-10.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"146"},{"groupId":"OG001","value":"125"}],"units":"Participants"}],"title":"Cognitive Functioning Score: Change from Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"25.37","value":"79.3"},{"groupId":"OG001","spread":"25.82","value":"78.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"211"},{"groupId":"OG001","value":"208"}],"units":"Participants"}],"title":"Social Functioning Score: Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"33.89","value":"-13.7"},{"groupId":"OG001","spread":"34.78","value":"-16.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"146"},{"groupId":"OG001","value":"122"}],"units":"Participants"}],"title":"Social Functioning Score: Change from Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"25.44","value":"38.5"},{"groupId":"OG001","spread":"24.24","value":"33.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"211"},{"groupId":"OG001","value":"210"}],"units":"Participants"}],"title":"Fatigue Score: Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"26.41","value":"6.6"},{"groupId":"OG001","spread":"31.22","value":"12.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"146"},{"groupId":"OG001","value":"126"}],"units":"Participants"}],"title":"Fatigue Score: Change from Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"11.39","value":"4.6"},{"groupId":"OG001","spread":"10.96","value":"4.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"211"},{"groupId":"OG001","value":"210"}],"units":"Participants"}],"title":"Nausea/Vomiting Score: Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"19.08","value":"2.4"},{"groupId":"OG001","spread":"15.00","value":"1.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"146"},{"groupId":"OG001","value":"125"}],"units":"Participants"}],"title":"Nausea/Vomiting Score: Change from Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"25.55","value":"20.9"},{"groupId":"OG001","spread":"26.42","value":"19.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"211"},{"groupId":"OG001","value":"210"}],"units":"Participants"}],"title":"Pain Score: Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"30.36","value":"5.8"},{"groupId":"OG001","spread":"33.34","value":"6.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"146"},{"groupId":"OG001","value":"125"}],"units":"Participants"}],"title":"Pain Score: Change from Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"29.83","value":"25.4"},{"groupId":"OG001","spread":"28.90","value":"24.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"211"},{"groupId":"OG001","value":"210"}],"units":"Participants"}],"title":"Dyspnoea Score: Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"28.95","value":"5.9"},{"groupId":"OG001","spread":"29.46","value":"5.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"146"},{"groupId":"OG001","value":"124"}],"units":"Participants"}],"title":"Dyspnoea Score: Change from Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"27.96","value":"27.2"},{"groupId":"OG001","spread":"30.68","value":"25.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"211"},{"groupId":"OG001","value":"210"}],"units":"Participants"}],"title":"Insomnia Score: Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"34.32","value":"3.2"},{"groupId":"OG001","spread":"34.09","value":"4.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"145"},{"groupId":"OG001","value":"124"}],"units":"Participants"}],"title":"Insomnia Score: Change from Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"29.29","value":"23.4"},{"groupId":"OG001","spread":"23.99","value":"15.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"211"},{"groupId":"OG001","value":"210"}],"units":"Participants"}],"title":"Appetite Loss Score: Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"38.68","value":"4.6"},{"groupId":"OG001","spread":"34.03","value":"16.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"146"},{"groupId":"OG001","value":"125"}],"units":"Participants"}],"title":"Appetite Loss Score: Change from Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"24.78","value":"14.7"},{"groupId":"OG001","spread":"22.47","value":"13.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"211"},{"groupId":"OG001","value":"210"}],"units":"Participants"}],"title":"Constipation Score: Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"29.56","value":"5.5"},{"groupId":"OG001","spread":"28.42","value":"5.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"146"},{"groupId":"OG001","value":"125"}],"units":"Participants"}],"title":"Constipation Score: Change from Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"18.84","value":"7.6"},{"groupId":"OG001","spread":"16.75","value":"7.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"211"},{"groupId":"OG001","value":"210"}],"units":"Participants"}],"title":"Diarrhoea Score: Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"22.80","value":"3.0"},{"groupId":"OG001","spread":"27.65","value":"1.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"146"},{"groupId":"OG001","value":"124"}],"units":"Participants"}],"title":"Diarrhoea Score: Change from Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"25.37","value":"14.2"},{"groupId":"OG001","spread":"26.76","value":"18.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"211"},{"groupId":"OG001","value":"208"}],"units":"Participants"}],"title":"Financial Difficulties Score: Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"27.03","value":"5.9"},{"groupId":"OG001","spread":"30.46","value":"7.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"146"},{"groupId":"OG001","value":"122"}],"units":"Participants"}],"title":"Financial Difficulties Score: Change from Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"14.90","value":"77.9"},{"groupId":"OG001","spread":"15.08","value":"80.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"211"},{"groupId":"OG001","value":"208"}],"units":"Participants"}],"title":"QLQ-C30 Summary Score: Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"18.84","value":"-6.1"},{"groupId":"OG001","spread":"17.75","value":"-8.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"145"},{"groupId":"OG001","value":"120"}],"units":"Participants"}],"title":"QLQ-C30 Summary Score: Change from Baseline"}],"denoms":[{"counts":[{"groupId":"OG000","value":"211"},{"groupId":"OG001","value":"210"}],"units":"Participants"}],"description":"The EORTC QLQ-C30 contains 30 items across 5 functional scales (physical, role, cognitive, emotional, and social), 9 symptom scales (fatigue, nausea and vomiting, pain, dyspnea, sleep disturbance, appetite loss, constipation, diarrhea, and financial difficulties) and a global health status/QOL scale. Most of the 30 items have 4 response levels (not at all, a little, quite a bit, and very much), with 2 questions relying on a 7-point numeric rating scale. Raw scores are converted into scale scores ranging from 0 to 100. For the functional scales and the global health status/QOL scale, higher scores represent better QOL; for the symptom scales, lower scores represent better QOL. The change from baseline at end of treatment is reported.","dispersionType":"Standard Deviation","groups":[{"description":"Participants were administered azacitidine 75 mg/m\\^2 IV or SC injection on Days 1 to 5, Days 8 and 9, in 28-day treatment cycles until disease progression or unacceptable toxicity or up to a maximum of 63 cycles.","id":"OG000","title":"Azacitidine 75 mg/m^2"},{"description":"Participants were administered azacitidine 75 mg/m\\^2 IV or SC injection on Days 1 to 5, Days 8 and 9 and pevonedistat 20 mg/m\\^2 IV infusion, on Days 1, 3, and 5 in 28-day treatment cycles until disease progression or unacceptable toxicity or up to a maximum of 63 cycles.","id":"OG001","title":"Pevonedistat 20 mg/m^2 + Azacitidine 75 mg/m^2"}],"paramType":"MEAN","populationDescription":"ITT Population included all participants who were randomized. All participants with PRO measurements at baseline and with data available at end of treatment were analyzed for this outcome measure.","reportingStatus":"POSTED","timeFrame":"Baseline, at approximately 58 months","title":"Change From Baseline in Health-Related Quality of Life (HRQOL) Using European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire- Core 30","type":"SECONDARY","unitOfMeasure":"score on a scale"}